Literature DB >> 11782534

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Lars M Bjorklund1, Rosario Sánchez-Pernaute, Sangmi Chung, Therese Andersson, Iris Yin Ching Chen, Kevin St P McNaught, Anna-Liisa Brownell, Bruce G Jenkins, Claes Wahlestedt, Kwang-Soo Kim, Ole Isacson.   

Abstract

Although implantation of fetal dopamine (DA) neurons can reduce parkinsonism in patients, current methods are rudimentary, and a reliable donor cell source is lacking. We show that transplanting low doses of undifferentiated mouse embryonic stem (ES) cells into the rat striatum results in a proliferation of ES cells into fully differentiated DA neurons. ES cell-derived DA neurons caused gradual and sustained behavioral restoration of DA-mediated motor asymmetry. Behavioral recovery paralleled in vivo positron emission tomography and functional magnetic resonance imaging data demonstrating DA-mediated hemodynamic changes in the striatum and associated brain circuitry. These results demonstrate that transplanted ES cells can develop spontaneously into DA neurons. Such DA neurons can restore cerebral function and behavior in an animal model of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782534      PMCID: PMC122367          DOI: 10.1073/pnas.022438099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  62 in total

1.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

2.  Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos.

Authors:  W C Smith; R M Harland
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

Review 3.  Vertebrate neural induction: inducers, inhibitors, and a new synthesis.

Authors:  P A Wilson; A Hemmati-Brivanlou
Journal:  Neuron       Date:  1997-05       Impact factor: 17.173

4.  Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.

Authors:  L Studer; V Tabar; R D McKay
Journal:  Nat Neurosci       Date:  1998-08       Impact factor: 24.884

5.  Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation.

Authors:  T Deacon; J Dinsmore; L C Costantini; J Ratliff; O Isacson
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

6.  Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease.

Authors:  C N Svendsen; M A Caldwell; J Shen; M G ter Borg; A E Rosser; P Tyers; S Karmiol; S B Dunnett
Journal:  Exp Neurol       Date:  1997-11       Impact factor: 5.330

7.  Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  C S Lee; M A Cenci; M Schulzer; A Björklund
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

Review 8.  Preventing levodopa-induced dyskinesias.

Authors:  C W Olanow; J A Obeso
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

9.  Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction.

Authors:  S H Hawley; K Wünnenberg-Stapleton; C Hashimoto; M N Laurent; T Watabe; B W Blumberg; K W Cho
Journal:  Genes Dev       Date:  1995-12-01       Impact factor: 11.361

10.  Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons.

Authors:  N S Haque; C J LeBlanc; O Isacson
Journal:  Cell Transplant       Date:  1997 May-Jun       Impact factor: 4.139

View more
  272 in total

1.  Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?

Authors:  Curt R Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

2.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Authors:  Sangmi Chung; Kai-C Sonntag; Therese Andersson; Lars M Bjorklund; Jae-Joon Park; Dong-Wook Kim; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

Review 3.  Using stem cells and iPS cells to discover new treatments for Parkinson's disease.

Authors:  Oliver Cooper; Penny Hallett; Ole Isacson
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 4.  Cell replacement therapy is the remedial solution for treating Parkinson's disease.

Authors:  Venkatesan Dhivya; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-06-30

5.  Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Masahito Kawabori; Mitsufumi Nishio; Yukari Takeda; Takao Koike; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-06-11       Impact factor: 6.829

6.  Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation.

Authors:  Hideo Shichinohe; Satoshi Kuroda; Kohsuke Kudo; Masaki Ito; Masahito Kawabori; Michiyuki Miyamoto; Mitsuhiro Nakanishi; Satoshi Terae; Kiyohiro Houkin
Journal:  Transl Stroke Res       Date:  2011-12-13       Impact factor: 6.829

7.  Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.

Authors:  Jisook Moon; Hyun-Seob Lee; Jun Mo Kang; Junpil Park; Amanda Leung; Sunghoi Hong; Sangmi Chung; Kwang-Soo Kim
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

8.  Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons.

Authors:  Oliver Cooper; Ole Isacson
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

9.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

10.  Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells.

Authors:  Ming Yang; Angela E Donaldson; Yubao Jiang; Lorraine Iacovitti
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.